Drug:
Reaction: DRUG HYPERSENSITIVITY
20250101 - 20251231
No. 101 - 200
No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
101 | 25124602 |
CA |
65 | 2 |
Asthma, Drug hypersensitivity, Oedema, Pneumonia, Wheezing, Dyspnoea, Vomiting, |
||||
AMLODIPINE BESYLATE, AMLODIPINE BESYLATE, AMLODIPINE BESYLATE, AMLODIPINE BESYLATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, AMINOPHYLLINE, AMINOPHYLLINE, CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN HYDROCHLORIDE, CLONAZEPAM, CLONAZEPAM, HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE, MONTELUKAST SODIUM, MONTELUKAST, MONTELUKAST SODIUM, MONTELUKAST, MONTELUKAST SODIUM, MONTELUKAST, MONTELUKAST SODIUM, MONTELUKAST, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN HYDROCHLORIDE, OMALIZUMAB, OMALIZUMAB, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, RISEDRONATE SODIUM, RISEDRONATE SODIUM, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE, |
||||
102 | 25124664 |
DE |
43 | 2 |
Hyperventilation, Pain in extremity, Fatigue, Drug hypersensitivity, Chest pain, |
||||
103 | 25125034 |
DE |
7 | 2 |
Condition aggravated, Drug ineffective, Drug hypersensitivity, |
||||
AMPHOTERICIN B, AMPHOTERICIN B, AMPHOTERICIN B, VORICONAZOLE, |
||||
104 | 25125048 |
DE |
18 | 2 |
Blindness, Drug hypersensitivity, Product use in unapproved indication, |
||||
OLANZAPINE, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, |
||||
105 | 25125164 |
US |
44 | 2 |
Drug hypersensitivity, |
||||
OZANIMOD HYDROCHLORIDE, DULOXETINE HYDROCHLORIDE, DULOXETINE, |
||||
106 | 25125436 |
US |
12 | 1 |
Drug hypersensitivity, |
||||
DUPILUMAB, |
||||
107 | 25125475 |
US |
||
Hepatic enzyme increased, Peripheral swelling, Pain in extremity, Musculoskeletal stiffness, Joint stiffness, Dyspnoea, Blood pressure decreased, Heart rate decreased, Loss of consciousness, Drug hypersensitivity, Weight abnormal, Ascites, Spinal fracture, Road traffic accident, Gait disturbance, Gait disturbance, |
||||
ACALABRUTINIB, ALLOPURINOL, FENTANYL, SPIRONOLACTONE, TORSEMIDE, |
||||
108 | 25125829 |
US |
85 | 2 |
Drug hypersensitivity, Pruritus, |
||||
NIRMATRELVIR AND RITONAVIR, LOSARTAN, |
||||
109 | 25126032 |
US |
12 | 1 |
Drug hypersensitivity, Pruritus, Eyelids pruritus, |
||||
DUPILUMAB, |
||||
110 | 25129787 |
|||
Drug hypersensitivity, |
||||
OCRELIZUMAB, |
||||
111 | 25129938 |
32 | 1 | |
Refusal of treatment by patient, Food refusal, Therapy interrupted, Priapism, Drug hypersensitivity, Ejaculation failure, |
||||
SULFAMETHOXAZOLE AND TRIMETHOPRIM, LORAZEPAM, PANTOPRAZOLE, VALPROIC ACID, |
||||
112 | 25115659 |
US |
1 | |
Drug hypersensitivity, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, TRAMETINIB, DABRAFENIB, |
||||
113 | 25115763 |
CA |
43 | 2 |
Abdominal discomfort, Abdominal pain upper, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Asthenia, Back injury, Blepharospasm, Blister, Blood cholesterol increased, Breast cancer stage III, Bursitis, C-reactive protein increased, Confusional state, Contraindicated product administered, Depression, Diarrhoea, Dizziness, Drug hypersensitivity, Drug ineffective, Drug intolerance, Dry mouth, Duodenal ulcer perforation, Epilepsy, Facet joint syndrome, Fibromyalgia, Folliculitis, Gait inability, Gastrooesophageal reflux disease, General physical health deterioration, Glossodynia, Hand deformity, Helicobacter infection, Hepatic enzyme increased, Hypercholesterolaemia, Hypertension, Hypoaesthesia, Impaired healing, Inflammation, Infusion related reaction, Infusion site reaction, Injury, Intentional product use issue, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Live birth, |
||||
BETAMETHASONE DIPROPIONATE, ALENDRONATE SODIUM, ACETAMINOPHEN AND CODEINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ERENUMAB-AOOE, ERENUMAB-AOOE, ERENUMAB-AOOE, ERENUMAB-AOOE, ATOMOXETINE HYDROCHLORIDE, ATOMOXETINE HYDROCHLORIDE, AZATHIOPRINE, BOTULINUM TOXIN TYPE A, BUPRENORPHINE, CANDESARTAN, CANDESARTAN, CELECOXIB, CELECOXIB, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, SECUKINUMAB, CYCLOBENZAPRINE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC, DICLOFENAC SODIUM, ERGOCALCIFEROL, AZELAIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, INFLIXIMAB, SARILUMAB, LEFLUNOMIDE, LEFLUNOMIDE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, OXYCODONE, PANTOPRAZOLE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, |
||||
114 | 25115849 |
US |
2 | |
Drug hypersensitivity, |
||||
EVOLOCUMAB, |
||||
115 | 25115946 |
US |
||
Drug hypersensitivity, Drug dependence, |
||||
OXYCODONE, OXYCODONE, OXYCODONE, OXYCODONE, FENTANYL, NASAL, SALINE, (SALINE), |
||||
116 | 25115950 |
US |
2 | |
Drug hypersensitivity, |
||||
OXYCODONE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, BENZONATATE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE, METOPROLOL TARTRATE, METOPROLOL, WARFARIN, SALICYLIC ACID, MEDICATED CORN REMOVERS, LIQUID WART REMOVER, ULTRA THIN CORN REMOVERS, MEDICATED PLANTAR WART REMOVER, EXTRA THICK CALLUS REMOVERS, CORN AND CALLUS REMOVER KIT, WART REMOVERS, WART REMOVER LIQUID, MEDICATED CALLUS REMOVERS, MEDICATED CALLUS REMOVERS EXTRA THICK, WART REMOVER GEL, WART REMOVER, CLEAR MEDICATED CORN REMOVERS, CORN REMOVERS, BOSYE BENEFITING HAIR LOTION, GEL CALLUS REMOVER, CALLUS REMOVERS, LIQUID CORN AND CALLUS REMOVER, WART REMOVER MEDICATED DISCS, WART REMOVER GEL TUBE, CORN AND CALLUS REMOVER LIQUID, PLANTAR WART REMOVER, ASTRINGENT, CORN AND CALLUS REMOVER, MEDICATED CORN REMOVER, GEL CORN REMOVER, HYDROGEL CLEAR WART REMOVER, PANTOPRAZOLE, |
||||
117 | 25115952 |
US |
1 | |
Drug hypersensitivity, Intentional dose omission, |
||||
DUPILUMAB, DUPILUMAB, |
||||
118 | 25116402 |
US |
||
Device delivery system issue, Wrong technique in product usage process, Drug hypersensitivity, Aphonia, Product dose omission issue, Malaise, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
119 | 25116610 |
US |
63 | 2 |
Drug hypersensitivity, |
||||
LENALIDOMIDE, |
||||
120 | 25116726 |
US |
2 | |
Drug hypersensitivity, |
||||
PREDNISOLONE ACETATE, |
||||
121 | 25117240 |
CA |
65 | 2 |
Asthma, Chest pain, Cough, Drug hypersensitivity, Dyspnoea, Malaise, Oedema, Pain, Pneumonia, Respiratory tract infection, Vomiting, Wheezing, |
||||
RITUXIMAB, OMALIZUMAB, |
||||
122 | 25118440 |
NL |
||
Drug hypersensitivity, Drug interaction, Product use in unapproved indication, |
||||
ALLOPURINOL, METHOTREXATE, METHOTREXATE SODIUM, |
||||
123 | 25118539 |
US |
45 | 2 |
Drug hypersensitivity, Urticaria, |
||||
DULAGLUTIDE, |
||||
124 | 25118572 |
US |
2 | |
Drug hypersensitivity, Dermatitis atopic, Inappropriate schedule of product administration, |
||||
COLCHICINE, DUPILUMAB, |
||||
125 | 25118578 |
US |
||
Illness, Fatigue, Pain, Drug hypersensitivity, |
||||
DOXYCYCLINE, DOXYCYCLINE HYCLATE, |
||||
126 | 25118893 |
US |
80 | 1 |
Drug hypersensitivity, |
||||
TAMSULOSIN HYDROCHLORIDE, ENZALUTAMIDE, MIRABEGRON, ZOLPIDEM TARTRATE, AMLODIPINE BESYLATE, BUPROPION HYDROCHLORIDE, BUPROPION, CLONAZEPAM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, PAROXETINE HYDROCHLORIDE, ROSUVASTATIN, |
||||
127 | 25119367 |
CA |
33 | 1 |
Lower respiratory tract infection bacterial, Inappropriate schedule of product administration, Drug hypersensitivity, Blood pressure systolic increased, Lower respiratory tract infection viral, Urticaria, |
||||
DICLOFENAC, DICLOFENAC SODIUM, RANITIDINE, IBUPROFEN SODIUM, IBUPROFEN, IBUPROFEN TABLETS, COATED, IBUPROFEN TABLET COATED, OMALIZUMAB, OMALIZUMAB, MONTELUKAST, |
||||
128 | 25120027 |
CA |
43 | 2 |
Abdominal discomfort, Abdominal pain upper, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Asthenia, Back injury, Blepharospasm, Blister, Blood cholesterol increased, Breast cancer stage III, Bursitis, C-reactive protein increased, Confusional state, Depression, Diarrhoea, Dizziness, Drug hypersensitivity, Drug ineffective, Drug intolerance, Dry mouth, Duodenal ulcer perforation, Epilepsy, Facet joint syndrome, Fibromyalgia, Folliculitis, Gait inability, Gastrooesophageal reflux disease, General physical health deterioration, Glossodynia, Hand deformity, Helicobacter infection, Hepatic enzyme increased, Hypercholesterolaemia, Hypertension, Hypoaesthesia, Impaired healing, Inflammation, Infusion related reaction, Infusion site reaction, Injury, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, |
||||
TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN AND CODEINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ERENUMAB-AOOE, ERENUMAB-AOOE, ATOMOXETINE HYDROCHLORIDE, ATOMOXETINE HYDROCHLORIDE, AZATHIOPRINE, BOTULINUM TOXIN TYPE A, BUPRENORPHINE, CANDESARTAN, CANDESARTAN, CELECOXIB, CELECOXIB, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, SECUKINUMAB, CYCLOBENZAPRINE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC, DICLOFENAC SODIUM, ERGOCALCIFEROL, AZELAIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, INFLIXIMAB, SARILUMAB, LEFLUNOMIDE, LEFLUNOMIDE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, OXYCODONE, PANTOPRAZOLE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, |
||||
129 | 25120289 |
US |
80 | 1 |
Drug hypersensitivity, |
||||
DUPILUMAB, LEVOTHYROXINE SODIUM, LORAZEPAM, NEBIVOLOL HYDROCHLORIDE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, |
||||
130 | 25120868 |
US |
1 | |
Drug hypersensitivity, |
||||
TREPROSTINIL, ENOXAPARIN SODIUM, MACITENTAN, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, SILDENAFIL CITRATE, SILDENAFIL, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, TREPROSTINIL, |
||||
131 | 25120869 |
CA |
33 | 1 |
Blood pressure systolic increased, Drug hypersensitivity, Lower respiratory tract infection bacterial, Lower respiratory tract infection viral, Urticaria, Inappropriate schedule of product administration, |
||||
OMALIZUMAB, OMALIZUMAB, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, DICLOFENAC, DICLOFENAC SODIUM, MONTELUKAST, RANITIDINE, |
||||
132 | 25122955 |
21 | 2 | |
Drug hypersensitivity, Tremor, |
||||
TRALOKINUMAB-LDRM, FLUTICASONE PROPIONATE, TRIPROLIDINE HCL, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, IBUPROFEN SODIUM, IBUPROFEN, IBUPROFEN TABLETS, COATED, IBUPROFEN TABLET COATED, IBUPROFEN, IBUPROFEN AND DIPHENHYDRAMINE CITRATE, |
||||
133 | 25109823 |
DE |
18 | 2 |
Blindness, Drug hypersensitivity, |
||||
ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, OLANZAPINE, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), |
||||
134 | 25109953 |
US |
73 | 2 |
Drug hypersensitivity, |
||||
PREGABALIN, ALBUTEROL SULFATE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CYCLOBENZAPRINE, DIAZEPAM, DIAZEPAM ORAL, DIAZEPAM ORAL SOLUTION (CONCENTRATE), DULOXETINE HYDROCHLORIDE, DULOXETINE, MONTELUKAST, PREDNISONE, SERTRALINE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, ERGOCALCIFEROL, |
||||
135 | 25110015 |
US |
1 | |
Drug hypersensitivity, Swelling face, Eczema, |
||||
DUPILUMAB, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, CETIRIZINE HYDROCHLORIDE, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, MELATONIN, FEXOFENADINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, |
||||
136 | 25110074 |
US |
58 | 2 |
Drug hypersensitivity, |
||||
TOCILIZUMAB, OMALIZUMAB, HYDROXYZINE, |
||||
137 | 25110112 |
CA |
40 | 2 |
Drug-induced liver injury, Drug hypersensitivity, Folliculitis, Gastrooesophageal reflux disease, Fatigue, Dyspnoea, Dyspepsia, Gait inability, Finger deformity, Drug intolerance, Gastrointestinal disorder, General physical health deterioration, |
||||
TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, ATOMOXETINE, ERENUMAB-AOOE, ERENUMAB-AOOE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, NAPROXEN, MEPOLIZUMAB, AZATHIOPRINE, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, LEFLUNOMIDE, LEFLUNOMIDE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, LAMOTRIGINE, LAMOTRIGINE, METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE ACETATE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, USTEKINUMAB, USTEKINUMAB, SULFASALAZINE, RAMIPRIL, RAMIPRIL, RAMIPRIL, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, METHOTREXATE, METHOTREXATE SODIUM, NAPROXEN, NAPROXEN SODIUM, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, APREMILAST, CANDESARTAN, BUPRENORPHINE, THIAMINE HYDROCHLORIDE, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, APREMILAST, APREMILAST, APREMILAST, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, INFLIXIMAB, INFLIXIMAB, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, MINOCYCLINE HYDROCHLORIDE, ERGOCALCIFEROL, NICOTINAMIDE, BOTULINUM TOXIN TYPE A, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, OXYCODONE, VITAMIN A, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, SARILUMAB, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, HYDROCORTISONE BUTYRATE, GOLD, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, MIRABEGRON, MIRABEGRON, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, MINOCYCLINE, MINOCYCLINE, GOLIMUMAB, PHENYLEPHRINE HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, RANITIDINE, RANITIDINE HYDROCHLORIDE, |
||||
138 | 25110144 |
US |
2 | |
Drug hypersensitivity, |
||||
IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
139 | 25110292 |
US |
54 | 2 |
Hypoaesthesia oral, Drug hypersensitivity, |
||||
ROMOSOZUMAB-AQQG, |
||||
140 | 25110302 |
CA |
65 | 2 |
Pneumonia, Oedema, Asthma, Drug hypersensitivity, Vomiting, |
||||
ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, AMLODIPINE, CALCIUM CARBONATE, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, CLONAZEPAM, FOLIC ACID, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN, PREDNISONE, RISEDRONATE SODIUM, ROSUVASTATIN, THEOPHYLLINE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, ERGOCALCIFEROL, OMALIZUMAB, RITUXIMAB, MONTELUKAST SODIUM, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, MOXIFLOXACIN HYDROCHLORIDE, RISEDRONATE SODIUM, ROSUVASTATIN CALCIUM, |
||||
141 | 25110385 |
GB |
61 | 2 |
Blindness, Burning sensation, Pain in extremity, Drug hypersensitivity, Injection site pain, Product availability issue, Incorrect dose administered, Off label use, |
||||
INSULIN DEGLUDEC, INSULIN DEGLUDEC, INSULIN DEGLUDEC, |
||||
142 | 25110485 |
US |
2 | |
Drug hypersensitivity, |
||||
PENICILLIN G SODIUM, |
||||
143 | 25110530 |
US |
82 | 2 |
Drug hypersensitivity, Asthma, Decreased immune responsiveness, |
||||
LENALIDOMIDE, |
||||
144 | 25110823 |
US |
1 | |
Drug hypersensitivity, |
||||
AMOXICILLIN AND CLAVULANATE POTASSIUM, |
||||
145 | 25110947 |
US |
2 | |
Drug hypersensitivity, |
||||
ETANERCEPT, TEZEPELUMAB-EKKO, |
||||
146 | 25111184 |
JP |
75 | 1 |
Dermatitis acneiform, Drug ineffective, Drug hypersensitivity, |
||||
PANITUMUMAB, REGORAFENIB, FLUOROURACIL, FLUOROURACIL, OXALIPLATIN, CETUXIMAB, |
||||
147 | 25111424 |
CA |
||
Asthma, Chest pain, Cough, Dyspnoea, Malaise, Nasal oedema, Oedema, Pain, Pneumonia, Respiratory tract infection, Vomiting, Wheezing, Drug hypersensitivity, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, AMLODIPINE BESYLATE, AMLODIPINE BESYLATE, AMLODIPINE BESYLATE, CALCIUM, CALCIUM, CALCIUM CARBONATE, CALCIUM CARBONATE, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, CIPROFLOXACIN HYDROCHLORIDE, CLONAZEPAM, CLONAZEPAM, ERGOCALCIFEROL, ERGOCALCIFEROL, FOLIC ACID, HYDROMORPHONE HYDROCHLORIDE, MONTELUKAST, MONTELUKAST, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN HYDROCHLORIDE, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, PREDNISONE, PREDNISONE, RISEDRONATE SODIUM, RISEDRONATE SODIUM, RITUXIMAB, RITUXIMAB, ROPIVACAINE HYDROCHLORIDE, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, THEOPHYLLINE, THEOPHYLLINE, TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE, |
||||
148 | 25111534 |
CA |
2 | |
Type 2 diabetes mellitus, Gait disturbance, Alopecia, Malaise, Back disorder, Fluid retention, Liver injury, Injury, Hypertension, Nausea, Sleep disorder, Memory impairment, Vomiting, Wound, Glossodynia, Hypoaesthesia, Blood cholesterol increased, Hepatic enzyme increased, Helicobacter infection, Oedema, Rash vesicular, Swelling, Abdominal discomfort, Diarrhoea, Pulmonary fibrosis, Anti-cyclic citrullinated peptide antibody positive, Stomatitis, Infusion related reaction, Pain, Breast cancer stage II, Decreased appetite, Peripheral swelling, X-ray abnormal, Pain in extremity, Grip strength decreased, Joint range of motion decreased, Dyspnoea, Pneumonia, General physical health deterioration, Dyspepsia, Psoriatic arthropathy, Mobility decreased, Pericarditis, Arthropathy, Gait inability, Joint swelling, Dislocation of vertebra, Drug hypersensitivity, Hypercholesterolaemia, Impaired healing, Condition aggravated, Psoriasis, Fatigue, Swollen joint count increased, Weight increased, Synovitis, Fibromyalgia, Folliculitis, Nasopharyngitis, Pruritus, Systemic lupus erythematosus, Infection, Abdominal pain upper, Contusion, Confusional state, Duodenal ulcer perforation, Muscle injury, Urticaria, Ill-defined disorder, Wound infection, Wheezing, Headache, Gastrointestinal disorder, Blister, Rash, Lower respiratory tract infection, Hypersensitivity, Subcutaneous drug absorption impaired, Irritable bowel syndrome, Myositis, Weight decreased, Chest pain, Sinusitis, Delirium, Discomfort, Depression, Arthralgia, Rheumatic fever, General symptom, Pemphigus, Amnesia, Migraine, Adjustment disorder with depressed mood, Sleep disorder due to general medical condition, insomnia type, Hand deformity, Musculoskeletal stiffness, Pustular psoriasis, Rheumatoid arthritis, Pyrexia, |
||||
DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, CALCIUM CARBONATE, VITAMIN C, DICLOFENAC, DICLOFENAC SODIUM, SECUKINUMAB, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, OXYCODONE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, ACETAMINOPHEN AND CODEINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, CERTOLIZUMAB PEGOL, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, ETANERCEPT, ETANERCEPT, ETANERCEPT, VEDOLIZUMAB, ALENDRONATE SODIUM, ADALIMUMAB, ADALIMUMAB, HYDROXYCHLOROQUINE, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, SARILUMAB, NAPROXEN, NAPROXEN SODIUM, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, APREMILAST, OXYCODONE HYDROCHLORIDE, OXYCODONE, PHENYLEPHRINE HYDROCHLORIDE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, GOLIMUMAB, GOLIMUMAB, USTEKINUMAB, SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, PREDNISONE, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, SECUKINUMAB, ERGOCALCIFEROL, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, SULFASALAZINE, QUETIAPINE FUMARATE, QUETIAPINE, LISINOPRIL, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, INFLIXIMAB, INFLIXIMAB, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, LEFLUNOMIDE, LEFLUNOMIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, OXYCODONE AND ACETAMINOPHEN, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, OXYCODONE AND ACETAMINOPHEN TABLETS, OXYCODONE AND ACETAMINOPHEN, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, OXYCODONE AND ACETAMINOPHEN TABLETS, FOLIC ACID, FOLIC ACID, HYDROXYCHLOROQUINE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, RAMIPRIL, LORAZEPAM, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, LANSOPRAZOLE, DESOGESTREL AND ETHINYL ESTRADIOL, CAFFEINE CITRATE, CALCIUM GLUCONATE, LORAZEPAM, ALENDRONATE SODIUM, |
||||
149 | 25111562 |
US |
||
Drug hypersensitivity, Drug ineffective, |
||||
CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, OXALIPLATIN, OXALIPLATIN, RANITIDINE, |
||||
150 | 25111563 |
US |
||
Drug hypersensitivity, Drug ineffective, |
||||
CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, OXALIPLATIN, OXALIPLATIN, OXALIPLATIN, OXALIPLATIN, OXALIPLATIN, OXALIPLATIN, OXALIPLATIN, OXALIPLATIN, RANITIDINE, RANITIDINE, RANITIDINE, RANITIDINE, |
||||
151 | 25111844 |
CA |
65 | 2 |
Asthma, Chest pain, Cough, Drug hypersensitivity, Dyspnoea, Malaise, Pneumonia, Respiratory tract infection, Vomiting, Wheezing, Oedema, Pain, |
||||
AMLODIPINE, CALCIUM CARBONATE, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, CLONAZEPAM, FOLIC ACID, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN, PREDNISONE, RISEDRONATE SODIUM, ROSUVASTATIN, THEOPHYLLINE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, ERGOCALCIFEROL, OMALIZUMAB, RITUXIMAB, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, MONTELUKAST SODIUM, |
||||
152 | 25112049 |
US |
||
Drug hypersensitivity, |
||||
METHYLPREDNISOLONE SODIUM SUCCINATE, |
||||
153 | 25112161 |
US |
||
Rheumatoid arthritis, Drug hypersensitivity, |
||||
DAPAGLIFLOZIN, |
||||
154 | 25112619 |
CA |
||
Lower respiratory tract infection, Blood pressure increased, Blood pressure systolic increased, Bronchitis, Cardiac disorder, Weight increased, Dizziness, Fatigue, Groin abscess, Headache, Heart rate decreased, Heart rate increased, Influenza, Nasopharyngitis, Nausea, Pain, Palpitations, Therapy non-responder, Drug hypersensitivity, Pruritus, Anaphylactic reaction, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, DICLOFENAC SODIUM AND MISOPROSTOL, MISOPROSTOL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, IBUPROFEN SODIUM, IBUPROFEN, IBUPROFEN TABLETS, COATED, IBUPROFEN TABLET COATED, FOLIC ACID, METHOTREXATE, METHOTREXATE SODIUM, PREDNISONE, |
||||
155 | 25112749 |
US |
1 | |
Drug hypersensitivity, |
||||
BIMEKIZUMAB, |
||||
156 | 25112814 |
US |
||
Drug hypersensitivity, Drug ineffective, Flushing, |
||||
CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, RANITIDINE, OXALIPLATIN, |
||||
157 | 25112825 |
US |
1 | |
Drug hypersensitivity, Cross sensitivity reaction, |
||||
BIMEKIZUMAB, INFLIXIMAB, |
||||
158 | 25112849 |
US |
2 | |
Drug hypersensitivity, |
||||
CELECOXIB, |
||||
159 | 25113104 |
US |
2 | |
Drug hypersensitivity, Urticaria, |
||||
BIMEKIZUMAB, |
||||
160 | 25113925 |
US |
||
Drug hypersensitivity, Pruritus, Urticaria, Flushing, Drug ineffective, |
||||
CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, OXALIPLATIN, RANITIDINE, |
||||
161 | 25114010 |
US |
46 | 2 |
Drug hypersensitivity, Drug ineffective, Anxiety, Hypotension, Urticaria, |
||||
CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, RANITIDINE, OXALIPLATIN, |
||||
162 | 25114037 |
US |
75 | 2 |
Urticaria, Dyspnoea, Pruritus, Throat tightness, Drug hypersensitivity, Incorrect dose administered, Product lot number issue, |
||||
NIRMATRELVIR AND RITONAVIR, |
||||
163 | 25114083 |
US |
||
Drug hypersensitivity, Drug ineffective, Abdominal pain, Urticaria, Pruritus allergic, Flushing, Back pain, Pyrexia, Chills, |
||||
CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, OXALIPLATIN, RANITIDINE, |
||||
164 | 25114084 |
CA |
||
Abdominal pain upper, Angina unstable, Aphonia, Arthralgia, Blood pressure increased, Bronchitis, Cardiomegaly, Cellulitis, Cough, Diarrhoea, Drug hypersensitivity, Dysphonia, Dyspnoea exertional, Eczema, Erythema, Fall, Fatigue, Hypoaesthesia, Illness, Insomnia, Joint dislocation, Multiple fractures, Myalgia, Oropharyngeal pain, Pain, Pain in extremity, Phlebitis, Pneumonia, Productive cough, Pruritus, Pyrexia, Respiratory tract congestion, Secretion discharge, Shoulder fracture, Sputum discoloured, Thrombophlebitis, Thrombosis, Urinary tract infection, Wrong technique in product usage process, Urticaria, |
||||
ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, CLINDAMYCIN PHOSPHATE, CLINDAMYCIN, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, APIXABAN, FLUTICASONE PROPIONATE, MONTELUKAST, MONTELUKAST SODIUM, TIOTROPIUM BROMIDE, ALBUTEROL SULFATE, |
||||
165 | 25114381 |
US |
2 | |
Drug hypersensitivity, |
||||
DUPILUMAB, |
||||
166 | 25114411 |
US |
48 | 2 |
Drug hypersensitivity, Vertigo, Eczema, |
||||
DUPILUMAB, TOPIRAMATE, TOPIRAMATE SPINKLE, |
||||
167 | 25114524 |
US |
1 | |
Drug hypersensitivity, |
||||
DUPILUMAB, CLINDAMYCIN PHOSPHATE, CLINDAMYCIN, |
||||
168 | 25114713 |
US |
||
Drug hypersensitivity, Drug ineffective, Pyrexia, Chills, |
||||
CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, RANITIDINE, OXALIPLATIN, |
||||
169 | 25114884 |
2 | ||
Haematological malignancy, Drug hypersensitivity, Diabetes mellitus, |
||||
DEFERASIROX, |
||||
170 | 25114988 |
29 | 2 | |
Drug hypersensitivity, |
||||
SUMATRIPTAN, SUMATRIPTAN SUCCINATE, ERGOCALCIFEROL, |
||||
171 | 25115012 |
IT |
82 | 2 |
Drug hypersensitivity, |
||||
PACLITAXEL, CARBOPLATIN, |
||||
172 | 25115032 |
US |
67 | 1 |
Drug hypersensitivity, Exercise tolerance decreased, |
||||
MAVACAMTEN, ROSUVASTATIN, |
||||
173 | 25115226 |
US |
59 | 1 |
Drug hypersensitivity, Anxiety, Pruritus, Hypotension, Drug ineffective, |
||||
CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, OXALIPLATIN, RANITIDINE, |
||||
174 | 25109183 |
US |
2 | |
Drug hypersensitivity, |
||||
SULFAMETHOXAZOLE AND TRIMETHOPRIM, CLINDAMYCIN PHOSPHATE, CLINDAMYCIN, PENICILLAMINE, ATENOLOL, OFATUMUMAB, LOSARTAN POTASSIUM, LOSARTAN, |
||||
175 | 25109372 |
US |
2 | |
Drug hypersensitivity, |
||||
176 | 25109433 |
US |
61 | 2 |
Injection site rash, Injection site pruritus, Injection site erythema, Drug hypersensitivity, Rash, Urticaria, |
||||
DUPILUMAB, |
||||
177 | 25113778 |
67 | 2 | |
Migraine, Hyperhidrosis, Chills, Pyrexia, Cough, Drug hypersensitivity, |
||||
CEFDINIR, LEVOTHYROXINE SODIUM, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
178 | 25107696 |
US |
2 | |
Drug hypersensitivity, |
||||
TREPROSTINIL, PILOCARPINE HYDROCHLORIDE, PILOCARPINE HYDROCHLORIDE OPHTHALMIC SOLUTION, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, ATORVASTATIN CALCIUM, TADALAFIL, URSODIOL, URSOSIOL, MACITENTAN, SPIRONOLACTONE, BUMETANIDE, OXYGEN, 0XYGEN, DIGOXIN, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ONDANSETRON HYDROCHLORIDE, |
||||
179 | 25107708 |
US |
69 | 2 |
Rash erythematous, Papule, Drug hypersensitivity, |
||||
CLINDAMYCIN PHOSPHATE, CLINDAMYCIN, COLCHICINE, CLINDAMYCIN PHOSPHATE, CLINDAMYCIN, |
||||
180 | 25107913 |
US |
51 | 2 |
Drug hypersensitivity, |
||||
DUPILUMAB, |
||||
181 | 25108256 |
IT |
60 | 1 |
Drug hypersensitivity, |
||||
ATEZOLIZUMAB, |
||||
182 | 25108275 |
CA |
44 | 2 |
X-ray abnormal, Diarrhoea, Hepatic enzyme increased, Abdominal discomfort, Abdominal pain, Abdominal pain upper, Adjustment disorder with depressed mood, Alopecia, Amnesia, Anti-cyclic citrullinated peptide antibody positive, Anxiety, Arthralgia, Arthritis, Arthropathy, Asthenia, Asthma, Autoimmune disorder, Blister, Blood cholesterol increased, Bone erosion, Breast cancer stage III, Bursitis, C-reactive protein abnormal, Chest pain, Colitis ulcerative, Condition aggravated, Contusion, Crohn^s disease, Delirium, Decreased appetite, Depression, Discomfort, Dislocation of vertebra, Dizziness, Drug hypersensitivity, Dry mouth, Duodenal ulcer perforation, Dyspepsia, Dyspnoea, Ear infection, Exostosis, Facet joint syndrome, Fatigue, Feeling hot, Fibromyalgia, Folliculitis, Foot deformity, Frequent bowel movements, Gait disturbance, Gastrointestinal disorder, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, SECUKINUMAB, SECUKINUMAB, LEFLUNOMIDE, |
||||
183 | 25108476 |
US |
2 | |
Drug hypersensitivity, |
||||
APIXABAN, APIXABAN, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
184 | 25108744 |
US |
38 | 2 |
Drug hypersensitivity, Product use in unapproved indication, |
||||
DUPILUMAB, SULFAMETHOXAZOLE AND TRIMETHOPRIM, |
||||
185 | 25108746 |
US |
||
Drug hypersensitivity, |
||||
TEZEPELUMAB-EKKO, |
||||
186 | 25102590 |
US |
2 | |
Drug hypersensitivity, Urticaria, |
||||
DUPILUMAB, TIRZEPATIDE, |
||||
187 | 25102607 |
US |
2 | |
Drug hypersensitivity, Dermatitis contact, |
||||
PERFLUOROHEXYLOCTANE, |
||||
188 | 25103159 |
US |
70 | 2 |
Drug hypersensitivity, |
||||
LENALIDOMIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, IXAZOMIB, POTASSIUM CHLORIDE, ACYCLOVIR, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, LEVOTHYROXINE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
189 | 25103214 |
CA |
65 | 2 |
Asthma, Drug hypersensitivity, Wheezing, Pneumonia, Vomiting, Oedema, Dyspnoea, |
||||
AMLODIPINE, CALCIUM CARBONATE, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, CLONAZEPAM, FOLIC ACID, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN, PREDNISONE, RISEDRONATE SODIUM, ROSUVASTATIN, THEOPHYLLINE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, ERGOCALCIFEROL, OMALIZUMAB, RITUXIMAB, ROPIVACAINE HYDROCHLORIDE, MONTELUKAST SODIUM, |
||||
190 | 25104094 |
US |
86 | 1 |
Drug hypersensitivity, |
||||
LENALIDOMIDE, |
||||
191 | 25104279 |
US |
||
Drug hypersensitivity, |
||||
TIRZEPATIDE, |
||||
192 | 25104660 |
US |
||
Drug hypersensitivity, Drug ineffective, |
||||
CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, OXALIPLATIN, OXALIPLATIN, RANITIDINE, |
||||
193 | 25104683 |
US |
2 | |
Drug hypersensitivity, |
||||
ERYTHROMYCIN ETHYLSUCCINATE, ERYTHROMYCIN, |
||||
194 | 25104692 |
US |
2 | |
Drug hypersensitivity, |
||||
ERYTHROMYCIN ETHYLSUCCINATE, ERYTHROMYCIN, |
||||
195 | 25104695 |
US |
2 | |
Drug hypersensitivity, |
||||
ERYTHROMYCIN, |
||||
196 | 25104850 |
US |
73 | 1 |
Drug hypersensitivity, |
||||
LENALIDOMIDE, |
||||
197 | 25105098 |
|||
Drug hypersensitivity, |
||||
FEBUXOSTAT, ALLOPURINOL, |
||||
198 | 25105188 |
US |
46 | 2 |
Systemic lupus erythematosus, Dyspnoea exertional, Drug hypersensitivity, |
||||
TADALAFIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, MACITENTAN, SOTATERCEPT-CSRK, |
||||
199 | 25105618 |
US |
2 | |
Drug hypersensitivity, Urticaria, |
||||
BEMPEDOIC ACID, |
||||
200 | 25106090 |
TR |
30 | 2 |
Drug hypersensitivity, Flushing, Dyspnoea, Hypertension, Palpitations, Off label use, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28